Nafamostat Mesylate Versus Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy in Sepsis-Associated Acute Kidney Injury
Clinical trial NCT07518303 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07518303
- Sponsor
- Jianfeng Xie
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-10
- Primary completion
- 2028-06-10
- Enrollment
- 1162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.